VEGFC and esophageal squamous cell carcinoma: TBL1XR1-induced upregulation of VEGF-C has been shown to drive lymphangiogenesis and lymphatic metastasis, positioning VEGF-C as a promising prognostic biomarker and therapeutic target in ESCC (15–21).